openPR Logo
Press release

Cannabinoid Therapy Market Greater Revenue Share by 2027(Based on therapy type, the global cannabinoid therapy market is segmented as: Tetrahydrocannabinol (THC) Cannabidiol (CBD) Cannabinol (CBN) Others)

03-21-2019 11:04 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Cannabinoid Therapy Market Greater Revenue Share by 2027(Based

A cannabinoid is a class of chemical compounds that change the neurotransmitter release in the brain by acting on cannabinoid receptors in the cells. Cannabinoids are derived from plants and are also referred to as the phytocannabinoids. Majority of the cannabinoids available for cannabinoid therapy are cannabis-driven, but there are several different plants from which cannabinoids can be derived as well. Approximately 70 plant compounds are identified for cannabinoids. Majority of these cannabinoids exhibit pharmacological activity and also at times, psychoactive effects. According to the study by Mechoulam and Hanus (2000), delta-9-tetrahydrocannabinol is the most intensively researched cannabinoid and exhibits the greatest psychoactivity among all the available cannabinoids. Cannabinoid therapy includes the use of these chemical compounds for various cancer cases, neuropathic disorders, spasticity conditions and is used for sedation as well. Legalization of the consumption of cannabis has increased the production and research related to cannabinoids. In the U.S., the District of Columbia and nine other states permit the use of recreational marijuana. Canada legalized the consumption of recreational marijuana in 2018. Cannabinoid therapy is being extensively used for sedation and treating nausea conditions in unfavorable environment.

Cannabinoid Therapy Market: Drivers

The growing popularity of cannabis among the youth and legalization of recreational cannabis globally are the major factors responsible for driving the cannabinoid therapy market. Increasing incidences of multiple sclerosis spasticity, anorexia nervosa related to HIV/AIDS, nausea, and cancer are also contributing to the demand for cannabinoid therapy during the forecast period. The first FDA-approved cannabis drug has been launched and several cannabinoid therapies are on the receiving end of FDA approval. This factor might also drive the cannabinoid therapy market during the forecast period. Legal issues and cannabis-related abuse might hinder the market growth of cannabinoid therapy. Certain side effects related to the use of cannabinoids like, hallucinations, lung problems, impaired mental functioning, blood pressure problems, etc. might also hinder the market for cannabinoid therapy during the forecast period.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=2833

Cannabinoid Therapy Market: Segmentation

Tentatively, the global cannabinoid therapy market can be segmented on the basis of Cephalometric X-ray type, technology, product type, end users, and geography.

Based on therapy type, the global cannabinoid therapy market is segmented as:

Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Cannabinol (CBN)
Others
Based on product type, the global cannabinoid therapy market is segmented as:

Oils
Capsules
Isolates
E-liquids
Topicals
Others
Based on applications, the global cannabinoid therapy market is segmented as:

Cannabinoid therapy for cancer
Cannabinoid therapy for spasticity
Cannabinoid therapy for neuropathic disorders
Others
Based on end users, the global cannabinoid therapy market is segmented as:

Hospitals
Cancer Centers
Military Healthcare Settings
Rehabilitation Centers
Others
Based on geography, the global cannabinoid therapy market is segmented as:

North America
Latin America
Europe
Japan
CIS & Russia
APEJ
Middle East & Africa
Cannabinoid Therapy Market: Overview

Epidiolex, which is manufactured by the United Kingdom-based company called GW Pharmaceuticals is the first ever marijuana-based medication that got approved by the US FDA (Food and Drug Administration) and has become available for sale in all the 50 states in 2018. Cannabinoid therapy is being efficiently used for various neuropathic syndromes as well as epileptic conditions like Dravet and Lennox-Gastaut syndrome. Tetrahydrocannabinol is the most common cannabinoid therapy product that is available in the market. Many synthetic cannabinoids have been previously approved by the FDA. Manufacturers dealing with the cannabinoid therapy market are also focused on combining THC and CBD to develop drugs for the treatment of conditions like muscle spasms and stiffness which are associated with multiple sclerosis. Sativex, a combination of CBD and THC is a cannabis-derived and FDA-approved drug. Cannabinoid therapy is also highly popular among cancer patients for easing symptoms or side effects caused by treatments like chemotherapy.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2833

Cannabinoid Therapy Market: Regional Outlook

North America’s cannabinoid therapy market is expected to grow the fastest over the period of forecast owing to the continued adoption and high FDA approval rate of the cannabinoid therapy in the region. Development of technologically-advanced cannabinoid therapy in the region is also expected to boost the market growth of cannabinoid therapy in the region. Europe’s cannabinoid therapy market is also anticipated to grow at a robust growth rate during the period of forecast because of increased demand and supply of cannabis-derived cannabinoids. The Asia-Pacific cannabinoid therapy market is estimated to grow at a decent rate during the period of forecast owing to the legal issues regarding the use of cannabis and low awareness about cannabinoid therapy.

Cannabinoid Therapy Market: Key Players

The major market participants operating in the global cannabinoid therapy market are Zynerba Pharmaceuticals, Cannabics Pharmaceuticals Inc., GW Pharmaceuticals PLC., Enecta, Alpha-CAT, Teewinot Life Sciences, Tilray, GD Pharma, Cyrelian Pty Ltd., Cape Bouvard Technologies Pty Ltd, MedReleaf Australia, and AusCann Group Holdings Pty Ltd.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes:

North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Chile
Peru
Rest of LATAM
Europe
EU – 4 (Germany, France, Italy, Spain)
UK
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep. Etc.)
Rest of Europe
CIS & Russia
Japan
APEJ
Greater China
India
Korea
ASEAN Countries
Rest of APEJ
Middle East & Africa
GCC Countries
Turkey
Iran
Israel
South Africa
Rest of MEA
Report highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Report Analysis@ https://www.factmr.com/report/2833/cannabinoid-therapy-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://theguardiantribune.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cannabinoid Therapy Market Greater Revenue Share by 2027(Based on therapy type, the global cannabinoid therapy market is segmented as: Tetrahydrocannabinol (THC) Cannabidiol (CBD) Cannabinol (CBN) Others) here

News-ID: 1665797 • Views: 278

More Releases from Fact.MR

Automatic Military Rifles Are Anticipated To Grow At A Higher Single Digit CAGR …
Military Rifle Market By Product (Assault Rifle, Light Machine Gun, General Purpose Machine Gun, Designated Marksman Rifle), By Firing Mode (Non-Automatic, Semi-Automatic, Fully Automatic), By Range, By Region - Global Market Insights 2029 Upsurge in the military spending by prominent countries has been observed in the last five years. Heightening safety concerns for citizens, territories, and public wealth, coupled with improved economic conditions have led to this increase. In the year 2019,
Expansion In The E-Commerce Sector To Augment The Sales Of Coffee Roasters Marke …
250 Pages Coffee Roaster Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider The unprecedented COVID-19 pandemic has affected the global economy to a great extent. Considering the food industry, one of the most important sectors of the economy, a tremendous impact has been witnessed on the entire process from the field to the consumer. The restrictions in the movement of workers, closure of food production facilities, and
2,3,6-Trimethylphenol (2,3,6 TMP)Will Accelerate At A Value CAGR Worth 4% By 203 …
2,3,6-Trimethylphenol (2,3,6 TMP) Market By Function (Intermediate, Perfuming Agent), By Application (Vitamin E, Cosmetics, Plastics, Pharmaceuticals), By Region - Global Market Insights 2020 to 2030 Global 2,3,6 TMP market is forecast to witness modest growth of around 4% over the forecast period of 2020-2030. For More Insights Into The Market, Request a Sample Of This Report:- https://www.factmr.com/connectus/sample?flag=S&rep_id=4608 2,3,6-Trimethylphenol Market Segmentation Fact.MR has studied the 2,3,6-Trimethylphenol market with detailed segmentation on the basis function, application and
Worldwide Demand For Hydrogen Generation Exhibits An Impressive Growth Trajector …
Hydrogen Generation Market Size, Trend Analysis & Competition Tracking By Technology (Coal Gasification, Steam Methane Reforming), By System (Merchant, Captive), By Application (Methanol Production, Ammonia Production, Petroleum Refining) - Global Market Insights Global hydrogen generation market exhibits an impressive growth trajectory of 7.5% CAGR during the forecast period (2019 - 2029). The declining cost of solar photovoltaics coupled with ascending sales of hydrogen fuel cell automobiles positively impact the hydrogen

All 5 Releases


More Releases for Cannabinoid

Medicinal Cannabis Market to Show Strong Growth | Leading players Medlab Clinica …
The Latest survey report on Global Medicinal Cannabis Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Medicinal Cannabis organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medlab Clinical, Oxford Cannabinoid Technologies, GW Pharmaceuticals, Botanix Pharmaceuticals, MGC Pharmaceuticals, Queensland
Global Synthetic Cannabinoid Market Growth Data Analysis 2020-2025
Market Overview The Synthetic Cannabinoid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. The global Synthetic Cannabinoid market size is expected to gain market growth in the forecast period of 2020 to 2025, with
Synthetic Cannabinoid Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Synthetic Cannabinoid market analysis, which studies the Synthetic Cannabinoid's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Synthetic Cannabinoid Market 2020-2025” Research Report categorizes the global Synthetic Cannabinoid market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
Cannabinoid Therapy Market Value Chain, Dynamics and Key Players 2018 to 2027(Ba …
A cannabinoid is a class of chemical compounds that change the neurotransmitter release in the brain by acting on cannabinoid receptors in the cells. Cannabinoids are derived from plants and are also referred to as the phytocannabinoids. Majority of the cannabinoids available for cannabinoid therapy are cannabis-driven, but there are several different plants from which cannabinoids can be derived as well. Approximately 70 plant compounds are identified for cannabinoids. Majority
Cannabinoid Therapy Market Future Forecast Indicates Impressive Growth Rate(Base …
A cannabinoid is a class of chemical compounds that change the neurotransmitter release in the brain by acting on cannabinoid receptors in the cells. Cannabinoids are derived from plants and are also referred to as the phytocannabinoids. Majority of the cannabinoids available for cannabinoid therapy are cannabis-driven, but there are several different plants from which cannabinoids can be derived as well. Approximately 70 plant compounds are identified for cannabinoids. Majority
Cannabinoid Therapy Market Estimated to Record Highest CAGR by 2018 to 2027
A cannabinoid is a class of chemical compounds that change the neurotransmitter release in the brain by acting on cannabinoid receptors in the cells. Cannabinoids are derived from plants and are also referred to as the phytocannabinoids. Majority of the cannabinoids available for cannabinoid therapy are cannabis-driven, but there are several different plants from which cannabinoids can be derived as well. Approximately 70 plant compounds are identified for cannabinoids. Majority